Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

09 January 2002

Markers of inflammation and coronary artery disease.

Gordon A Ferns, Salam M Saadeddin

Med Sci Monit 2002; 8(1): RA5-12 :: ID: 420955

Abstract

Many recent experimental and clinical studies have provided evidence forthe presence of inflammation in atherosclerotic lesions. Ongoing inflammatory reactions within coronaryatherosclerotic plaques are increasingly thought to be crucial determinants of the clinical course ofpatients with coronary artery disease (CAD). These facts lead to a search for reliable markers reflectingthe inflammatory process in the atherosclerotic plaques. Circulating markers may consist of cytokinesdirectly released from inflammatory cells present in the plaques and tissues exposed to recurrent ischemiaas well as other reactants produced in response to these cytokines such as adhesion molecules and acutephase proteins. Recent studies suggest that markers of inflammation may reflect different aspects ofthe atherothrombotic process at different points in the continuum of acute coronary syndromes, have apotential role for the prediction of risk for developing CAD, and may correlate with severity and futurerisk for CAD. In spite of these findings, the clinical utility of measuring these markers is limitedby the availability of reproducible diagnostic test assays. In addition, it remains to be determinedwhether markers of inflammation actually have a causal relation with cardiovascular disease, or simplyreflect the underlying disease process. Such determination becomes important with the potential use ofthese markers in targeting preventive therapies. Therefore, further well-designed prospective evaluationof each of these markers is needed before their use in routine practice.

Keywords: Acute-Phase Proteins, Apolipoproteins, Biological Markers, C-Reactive Protein, Cell Adhesion Molecules, Coronary Arteriosclerosis, Cytokines, Fibrinogen, Interleukin-1, Interleukin-6, Serum Amyloid A Protein

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750